Isatuximab: Ph III ICARIA-MM started

Sanofi’s Sanofi Genzyme unit began the open-label, international Phase III ICARIA-MM trial to compare isatuximab in combination with Imnovid/Pomalyst pomalidomide and dexamethasone vs. Imnovid and de...